JP2013532658A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013532658A5 JP2013532658A5 JP2013520785A JP2013520785A JP2013532658A5 JP 2013532658 A5 JP2013532658 A5 JP 2013532658A5 JP 2013520785 A JP2013520785 A JP 2013520785A JP 2013520785 A JP2013520785 A JP 2013520785A JP 2013532658 A5 JP2013532658 A5 JP 2013532658A5
- Authority
- JP
- Japan
- Prior art keywords
- glyburide
- administration
- continuous infusion
- medicament
- period
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229960004580 glibenclamide Drugs 0.000 claims 77
- ZNNLBTZKUZBEKO-UHFFFAOYSA-N glyburide Chemical compound COC1=CC=C(Cl)C=C1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)NC2CCCCC2)C=C1 ZNNLBTZKUZBEKO-UHFFFAOYSA-N 0.000 claims 77
- 238000001802 infusion Methods 0.000 claims 36
- 239000003814 drug Substances 0.000 claims 34
- 238000011010 flushing procedure Methods 0.000 claims 9
- 208000028867 ischemia Diseases 0.000 claims 6
- 230000001225 therapeutic effect Effects 0.000 claims 6
- 238000000034 method Methods 0.000 claims 4
- 206010021143 Hypoxia Diseases 0.000 claims 3
- 208000006011 Stroke Diseases 0.000 claims 3
- 208000030886 Traumatic Brain injury Diseases 0.000 claims 3
- 206010047281 Ventricular arrhythmia Diseases 0.000 claims 3
- 208000027418 Wounds and injury Diseases 0.000 claims 3
- 230000006378 damage Effects 0.000 claims 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 3
- 208000035475 disorder Diseases 0.000 claims 3
- 230000007954 hypoxia Effects 0.000 claims 3
- 208000014674 injury Diseases 0.000 claims 3
- 208000037906 ischaemic injury Diseases 0.000 claims 3
- 208000010125 myocardial infarction Diseases 0.000 claims 3
- 210000000056 organ Anatomy 0.000 claims 3
- 230000007170 pathology Effects 0.000 claims 3
- 239000004800 polyvinyl chloride Substances 0.000 claims 3
- 230000035939 shock Effects 0.000 claims 3
- 208000020431 spinal cord injury Diseases 0.000 claims 3
- 230000009529 traumatic brain injury Effects 0.000 claims 3
- 229940079593 drug Drugs 0.000 claims 2
- 238000001990 intravenous administration Methods 0.000 claims 2
- 239000004698 Polyethylene Substances 0.000 claims 1
- 239000008280 blood Substances 0.000 claims 1
- 210000004369 blood Anatomy 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 239000000463 material Substances 0.000 claims 1
- -1 polyethylene Polymers 0.000 claims 1
- 229920000573 polyethylene Polymers 0.000 claims 1
- 229920000915 polyvinyl chloride Polymers 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36568910P | 2010-07-19 | 2010-07-19 | |
| US61/365,689 | 2010-07-19 | ||
| PCT/US2011/044397 WO2012012347A2 (en) | 2010-07-19 | 2011-07-18 | Methods of intravenous administration of glyburide and other drugs |
Related Child Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015212868A Division JP6179574B2 (ja) | 2010-07-19 | 2015-10-29 | グリブリドおよび他の薬剤の静脈内投与方法 |
| JP2017051153A Division JP6506335B2 (ja) | 2010-07-19 | 2017-03-16 | グリブリドおよび他の薬剤の静脈内投与方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013532658A JP2013532658A (ja) | 2013-08-19 |
| JP2013532658A5 true JP2013532658A5 (enExample) | 2015-05-28 |
| JP6188021B2 JP6188021B2 (ja) | 2017-08-30 |
Family
ID=45497399
Family Applications (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013520785A Active JP6188021B2 (ja) | 2010-07-19 | 2011-07-18 | グリブリドおよび他の薬剤の静脈内投与方法 |
| JP2015212868A Active JP6179574B2 (ja) | 2010-07-19 | 2015-10-29 | グリブリドおよび他の薬剤の静脈内投与方法 |
| JP2017051153A Active JP6506335B2 (ja) | 2010-07-19 | 2017-03-16 | グリブリドおよび他の薬剤の静脈内投与方法 |
| JP2018230763A Active JP6795571B2 (ja) | 2010-07-19 | 2018-12-10 | グリブリドおよび他の薬剤の静脈内投与方法 |
| JP2020019464A Pending JP2020073595A (ja) | 2010-07-19 | 2020-02-07 | グリブリドおよび他の薬剤の静脈内投与方法 |
Family Applications After (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015212868A Active JP6179574B2 (ja) | 2010-07-19 | 2015-10-29 | グリブリドおよび他の薬剤の静脈内投与方法 |
| JP2017051153A Active JP6506335B2 (ja) | 2010-07-19 | 2017-03-16 | グリブリドおよび他の薬剤の静脈内投与方法 |
| JP2018230763A Active JP6795571B2 (ja) | 2010-07-19 | 2018-12-10 | グリブリドおよび他の薬剤の静脈内投与方法 |
| JP2020019464A Pending JP2020073595A (ja) | 2010-07-19 | 2020-02-07 | グリブリドおよび他の薬剤の静脈内投与方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (9) | US8946293B2 (enExample) |
| EP (3) | EP3339190A1 (enExample) |
| JP (5) | JP6188021B2 (enExample) |
| KR (8) | KR20200054319A (enExample) |
| CN (2) | CN103108637B (enExample) |
| CA (3) | CA2806069C (enExample) |
| WO (1) | WO2012012347A2 (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI1010576A2 (pt) | 2009-05-11 | 2016-03-15 | Berg Biosystems Llc | métodos para tratamento de distúrbios oncológicos usando transferidores epimetabólicos, moléculas intracelulares multidimensionais ou influenciadores ambientais. |
| KR20200054319A (ko) | 2010-07-19 | 2020-05-19 | 바이오젠 체사피크 엘엘씨 | 글리부리드 및 다른 약물의 정맥내 투여를 위한 방법 |
| PL2616064T3 (pl) * | 2010-10-21 | 2020-02-28 | Rtu Pharmaceuticals Llc | Gotowe do zastosowania formulacje ketorolaku |
| EP2694463B8 (en) | 2011-04-04 | 2019-10-09 | Berg LLC | Treating central nervous system tumors with coenzyme q10 |
| WO2013169939A2 (en) | 2012-05-08 | 2013-11-14 | Aeromics, Llc | New methods |
| SG11201508272YA (en) | 2013-04-08 | 2015-11-27 | Berg Llc | Treatment of cancer using coenzyme q10 combination therapies |
| JP6595478B2 (ja) | 2013-09-04 | 2019-10-23 | バーグ エルエルシー | コエンザイムｑ１０の連続注入によるがんの治療方法 |
| CA2929821A1 (en) | 2013-11-06 | 2015-05-14 | Aeromics, Inc. | 2-{[3,5-bis(trifluoromethyl)phenyl]carbamoyl}-4-chlorophenyl dihydrogen phosphate formulations and kits |
| ES2927482T3 (es) | 2015-05-29 | 2022-11-07 | Univ Maryland | Métodos para reducir o prevenir el daño de la íntima causado por la estimulación mecánica de las células endoteliales |
| IL258509B2 (en) * | 2015-10-07 | 2023-04-01 | Biogen Chesapeake Llc | Methods for treating injuries or conditions related to edema in the central nervous system |
| WO2017087576A1 (en) | 2015-11-16 | 2017-05-26 | Berg Llc | Methods of treatment of temozolomide-resistant glioma using coenzyme q10 |
| KR102646250B1 (ko) | 2016-07-29 | 2024-03-11 | 레메디 파마슈티칼즈, 인크. | Sur1-trpm4 통로 저해제를 이용하는 의학적 치료 방법 |
| US11382881B2 (en) | 2017-05-05 | 2022-07-12 | Nino Sorgente | Methods and compositions for diagnosing and treating glaucoma |
| CA3062170A1 (en) | 2017-05-05 | 2018-11-08 | Nino Sorgente | Methods and compositions for improving eye health |
| CN108078999B (zh) * | 2017-12-22 | 2020-08-14 | 沈阳药科大学 | 用于防治缺血性脑卒中的药物组合物及其制备方法和用途 |
| US12492166B2 (en) | 2020-07-17 | 2025-12-09 | Shanghai Senhui Medicine Co., Ltd | Sulfonylurea derivative and medical uses thereof |
| US12251388B1 (en) | 2024-05-09 | 2025-03-18 | Remedy Pharmaceuticals, Inc. | Methods of treating ischemic stroke at risk for cerebral or cerebellar edema |
| US12251389B1 (en) | 2024-04-22 | 2025-03-18 | Remedy Pharmaceuticals, Inc. | Methods of treating ischemic stroke at risk for cerebral or cerebellar edema |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5856360A (en) * | 1996-05-03 | 1999-01-05 | Children's Hospital Medical Center | Pharmaceutical method for the treatment of severe blood loss and for the inhibition or treatment of hemorrhagic shock |
| DE10300323A1 (de) * | 2003-01-09 | 2004-10-14 | Baxter Healthcare S.A. | Sicherheitsbehälter mit erhöhter Bruch und Splitterfestigkeit sowie kontaminationsfreier Außenfläche für biologisch aktive Substanzen und Verfahren zu deren Herstellung |
| US20080220441A1 (en) | 2001-05-16 | 2008-09-11 | Birnbaum Eva R | Advanced drug development and manufacturing |
| EP2438913B1 (en) | 2002-03-20 | 2020-05-06 | University of Maryland, Baltimore | A non-selective cation channel in neural cells and compounds that block the channel for use in treating brain swelling |
| US8980952B2 (en) * | 2002-03-20 | 2015-03-17 | University Of Maryland, Baltimore | Methods for treating brain swelling with a compound that blocks a non-selective cation channel |
| US20040073192A1 (en) * | 2002-10-15 | 2004-04-15 | Flament-Garcia Mary Jane | Intravenous fluid delivery set |
| US20050148928A1 (en) * | 2003-12-31 | 2005-07-07 | Medtronic Minimed, Inc. | Multiple layer tubing and method of making same |
| CA2566873C (en) | 2004-05-20 | 2013-02-12 | Diamedica Inc. | Use of drug combinations for treating insulin resistance |
| CN101043891A (zh) | 2004-09-18 | 2007-09-26 | 巴尔的摩马里兰大学 | 靶向NCCa－ATP通道的治疗剂及其使用方法 |
| CA2580606A1 (en) * | 2004-09-18 | 2006-03-30 | University Of Maryland, Baltimore | Therapeutic agents targeting the ncca-atp channel and methods of use thereof |
| EP1833734A4 (en) * | 2004-12-23 | 2012-06-20 | Hospira Inc | ORIFICE CLOSURE SYSTEM FOR INTRAVENOUS FLUID CONTAINER |
| RS52657B (sr) * | 2006-09-29 | 2013-06-28 | Infa S.A. | Sistem pakovanja za farmaceutske smeše i komplet za intravensku primenu |
| EP2167107B1 (en) | 2007-06-22 | 2016-12-14 | University of Maryland, Baltimore | Inhibitors of ncca-atp channels for therapy |
| US20110034560A1 (en) * | 2008-01-29 | 2011-02-10 | Sven Jacobson | Liquid formulations of compounds active at sulfonylurea receptors |
| CN101229316B (zh) * | 2008-01-31 | 2010-08-25 | 广东药学院 | 一种知母提取物 |
| KR20200054319A (ko) | 2010-07-19 | 2020-05-19 | 바이오젠 체사피크 엘엘씨 | 글리부리드 및 다른 약물의 정맥내 투여를 위한 방법 |
-
2011
- 2011-07-18 KR KR1020207012483A patent/KR20200054319A/ko not_active Ceased
- 2011-07-18 US US13/811,037 patent/US8946293B2/en active Active
- 2011-07-18 CA CA2806069A patent/CA2806069C/en active Active
- 2011-07-18 EP EP18157269.4A patent/EP3339190A1/en not_active Ceased
- 2011-07-18 CA CA3101711A patent/CA3101711C/en active Active
- 2011-07-18 EP EP11810231.8A patent/EP2595633A4/en not_active Ceased
- 2011-07-18 KR KR1020197007606A patent/KR20190031592A/ko not_active Ceased
- 2011-07-18 KR KR1020257005414A patent/KR20250026419A/ko active Pending
- 2011-07-18 KR KR1020137004062A patent/KR20130133165A/ko not_active Ceased
- 2011-07-18 WO PCT/US2011/044397 patent/WO2012012347A2/en not_active Ceased
- 2011-07-18 CA CA3225438A patent/CA3225438A1/en active Pending
- 2011-07-18 KR KR1020237040323A patent/KR20230165363A/ko not_active Ceased
- 2011-07-18 JP JP2013520785A patent/JP6188021B2/ja active Active
- 2011-07-18 KR KR1020177029156A patent/KR101917975B1/ko active Active
- 2011-07-18 CN CN201180044843.6A patent/CN103108637B/zh active Active
- 2011-07-18 KR KR1020217042532A patent/KR20220000943A/ko not_active Ceased
- 2011-07-18 KR KR1020187032015A patent/KR20180123176A/ko not_active Ceased
- 2011-07-18 EP EP19178203.6A patent/EP3586850A1/en active Pending
- 2011-07-18 CN CN201810945946.3A patent/CN109172363A/zh active Pending
-
2014
- 2014-10-28 US US14/525,992 patent/US9254259B2/en active Active
-
2015
- 2015-10-08 US US14/878,232 patent/US9561176B2/en active Active
- 2015-10-29 JP JP2015212868A patent/JP6179574B2/ja active Active
-
2017
- 2017-02-06 US US15/425,874 patent/US10052280B2/en active Active
- 2017-03-16 JP JP2017051153A patent/JP6506335B2/ja active Active
- 2017-08-25 US US15/686,989 patent/US10391053B2/en active Active
-
2018
- 2018-12-10 JP JP2018230763A patent/JP6795571B2/ja active Active
-
2019
- 2019-07-02 US US16/459,893 patent/US10786445B2/en active Active
-
2020
- 2020-02-07 JP JP2020019464A patent/JP2020073595A/ja active Pending
- 2020-09-24 US US17/030,925 patent/US11559481B2/en active Active
-
2023
- 2023-01-20 US US18/157,302 patent/US12226521B2/en active Active
-
2025
- 2025-01-09 US US19/015,309 patent/US20250221924A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013532658A5 (enExample) | ||
| JP6795571B2 (ja) | グリブリドおよび他の薬剤の静脈内投与方法 | |
| US11498959B2 (en) | Anti-CGRP antibody formulation | |
| ES2762250T5 (es) | Tratamiento combinado del cáncer | |
| Doepker et al. | High-dose insulin and intravenous lipid emulsion therapy for cardiogenic shock induced by intentional calcium-channel blocker and beta-blocker overdose: a case series | |
| JP2017031213A5 (enExample) | ||
| JP2014528474A5 (enExample) | ||
| JP2018533589A5 (enExample) | ||
| JP2013541583A5 (enExample) | ||
| JP2010523714A5 (enExample) | ||
| JP2019517542A5 (enExample) | ||
| JP2012525393A5 (enExample) | ||
| JP2014524480A5 (enExample) | ||
| JP2016539921A5 (enExample) | ||
| JP2023120445A (ja) | テルリプレシン組成物およびその使用方法 | |
| JP2018531938A5 (enExample) | ||
| JP2014526562A5 (enExample) | ||
| RU2019134416A (ru) | Фармацевтические композиции | |
| JP2016527202A5 (enExample) | ||
| JP2017533211A5 (enExample) | ||
| JP2014511365A5 (enExample) | ||
| JP2014510782A5 (enExample) | ||
| JP2020510043A5 (enExample) | ||
| JPWO2021045159A5 (enExample) | ||
| JP2006514681A5 (enExample) |